Citation:Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, et al 2008

Citation

Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008 Apr 1;26(10):1626-34 Available from: http://www.ncbi.nlm.nih.gov/pubmed/18316791.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Molecular pathology and biomarkers – implications for systemic therapy